European guidelines have not recommended hepatitis C interferon therapy for hepatitis C – Sohu health over the past two years because of a variety of direct antiviral drugs listed, completely changed the hepatitis C virus infection antiviral treatment strategy, the treatment of hepatitis C in interferon free shorter course and better curative effect and less side effects, a wide selection of all oral treatment time. Since 2015, the European guidelines no longer recommend the use of low virological response and drug side effects of interferon or pegylated interferon combined with ribavirin, also use the first generation protease inhibitor bosai kpwe and Trapp Wei is not recommended. C Guide 2015 Europe also recommended treatment combined with Sago kpwe pegylated interferon and ribavirin, as more antiviral drugs for the treatment of hepatitis C listed since 2016, with all disappeared from the interferon program guide. In 2016 the European guidelines recommend different HCV genotypes of hepatitis C virus infection without interferon treatment is shown in Table 1 Table 1 European guidelines recommend no hepatitis C hepatitis C treatment guidelines for interferon treatment with European genotypes of hepatitis C virus infection, hepatitis C and hepatitis C in the United States guide guide WHO in 2016 does not recommend the use of interferon treatment of chronic hepatitis C. In our country, some direct antiviral drugs for the treatment of hepatitis C has completed clinical trials, but so far our country does not have a direct antiviral drug approved, hepatitis C virus infection in China still need to use many adverse reactions, poor efficacy of interferon or from abroad (or smuggling black) buy direct antiviral therapy. Today write this blog is to introduce foreign progress in the treatment of hepatitis C, two is the examination and approval administration urged accelerated hepatitis C drugs, hepatitis C virus infection to our country as soon as possible to get a safe and effective treatment.